← Leaderboards
Andrea Ballabio
Fondazione Telethon
$6,150,001
Attributed
$7,222,149
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $552.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,222,149 · 4
By mechanism
R01$7,212,149 · 3
R13$10,000 · 1
Top collaborators
- Roberto Zoncu4 shared
Others in their field
Top investigators on “Biogenesis”
- James E. Gern · University Of Wisconsin-Madison$82,846,335
- Bruce M Spiegelman · Dana-Farber Cancer Inst$26,576,820
- Thomas G Bernhardt · Harvard Medical School$19,198,051
- Dana Dabelea · University Of Colorado Denver$18,802,156
- Daniel E Kahne · Harvard University$16,559,803
- Suresh Subramani · University Of California San Diego$16,335,425
Research focus
BiogenesisLysosomesMediatingCellsPhenotypeMouse ModelTranscription FactorOverexpressionScienceIn VivoBaseMolecularDisease PhenotypeTranscriptional RegulationNeurodegenerative DisordersSignal PathwayPathway InteractionsHuman DiseaseAffectGenesLysosomal Storage DiseasesMetabolicPhosphorylationAutophagocytosis
Grant awards (19)
Dissecting and targeting lysosomal signaling in kidney tumorigenesis$543,653
R01 · FY2025 · CA
Dissecting and targeting lysosomal signaling in kidney tumorigenesis$516,093
R01 · FY2024 · CA
Dissecting and targeting lysosomal signaling in kidney tumorigenesis$532,176
R01 · FY2023 · CA
Dissecting and targeting lysosomal signaling in kidney tumorigenesis$552,374
R01 · FY2022 · CA
Modulation of Cellular Clearance to Treat Human Disease$346,719
R01 · FY2020 · NS · contact PI
Modulation of Cellular Clearance to Treat Human Disease$346,719
R01 · FY2019 · NS · contact PI
Modulation of Cellular Clearance to Treat Human Disease$346,719
R01 · FY2018 · NS · contact PI
Modulation of Cellular Clearance to Treat Human Disease$346,719
R01 · FY2017 · NS · contact PI
MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASE$342,344
R01 · FY2016 · NS · contact PI
2017 Lysosomal Diseases Gordon Research Conference and Gordon Research Seminar$10,000
R13 · FY2016 · NS · contact PI
MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASE$342,344
R01 · FY2015 · NS · contact PI
MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASE$338,921
R01 · FY2014 · NS · contact PI
MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASE$330,362
R01 · FY2013 · NS · contact PI
MODULATION OF CELLULAR CLEARANCE TO TREAT HUMAN DISEASE$342,344
R01 · FY2012 · NS · contact PI
Ocular Albinism type 1: from molecular bases to gene delivery$412,414
R01 · FY2007 · EY · contact PI
OA1: from molecular bases to gene delivery$402,652
R01 · FY2006 · EY · contact PI
OA1: from molecular bases to gene delivery$400,331
R01 · FY2005 · EY
OA1: from molecular bases to gene delivery$388,673
R01 · FY2004 · EY
Ocular Albinism 1: from molecular bases to gene delivery$380,592
R01 · FY2003 · EY